- Home
- HRMY vs APOG Comparison
HRMY vs APOG Comparison
Compare HRMY & APOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- APOG
- Stock Information
- Founded
- HRMY 2017
- APOG 1949
- Country
- HRMY United States
- APOG United States
- Employees
- HRMY N/A
- APOG N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- APOG Auto Parts:O.E.M.
- Sector
- HRMY Health Care
- APOG Consumer Discretionary
- Exchange
- HRMY Nasdaq
- APOG Nasdaq
- Market Cap
- HRMY 2.1B
- APOG 1.8B
- IPO Year
- HRMY 2020
- APOG N/A
- Fundamental
- Price
- HRMY $33.22
- APOG $82.03
- Analyst Decision
- HRMY Buy
- APOG Hold
- Analyst Count
- HRMY 9
- APOG 1
- Target Price
- HRMY $47.00
- APOG $75.00
- AVG Volume (30 Days)
- HRMY 1.3M
- APOG 141.8K
- Earning Date
- HRMY 10-29-2024
- APOG 12-19-2024
- Dividend Yield
- HRMY N/A
- APOG 1.22%
- EPS Growth
- HRMY N/A
- APOG 4.28
- EPS
- HRMY 2.11
- APOG 4.74
- Revenue
- HRMY $681,879,000.00
- APOG $1,375,510,000.00
- Revenue This Year
- HRMY $24.63
- APOG N/A
- Revenue Next Year
- HRMY $18.04
- APOG $4.80
- P/E Ratio
- HRMY $15.77
- APOG $17.31
- Revenue Growth
- HRMY 25.83
- APOG N/A
- 52 Week Low
- HRMY $26.03
- APOG $44.46
- 52 Week High
- HRMY $41.61
- APOG $87.93
- Technical
- Relative Strength Index (RSI)
- HRMY 44.15
- APOG 57.36
- Support Level
- HRMY $32.37
- APOG $74.72
- Resistance Level
- HRMY $36.68
- APOG $87.93
- Average True Range (ATR)
- HRMY 2.02
- APOG 2.04
- MACD
- HRMY -0.07
- APOG 0.13
- Stochastic Oscillator
- HRMY 20.73
- APOG 55.34
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
About APOG Apogee Enterprises Inc.
Apogee Enterprises Inc provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. Its segments are Architectural Framing Systems; Architectural Glass; Architectural Services and Large-Scale Optical Technologies (LSO). It generates maximum revenue from the Architectural Framing Systems segment. The Architectural Framing Systems segment designs, engineers, fabricates, and finishes the aluminum frames used in customized aluminum and glass windows, curtainwall, storefront, and entrance systems comprising the outside skin and entrances of commercial, institutional, and others. Geographically, it derives a majority of its revenue from the United States.